Kaboré NF - Search Results

1

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).

Kaboré NF, Ouédraogo S, Mamguem AK, Traoré IT, Kania D, Badolo H, Sanou G, Koné A, Yara M, Kagoné T, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Billa O, Paradis G, Dabakuyo-Yonli TS, Tinto H. Kaboré NF, et al. BMC Infect Dis. 2023 Jun 12;23(1):394. doi: 10.1186/s12879-023-08361-2. BMC Infect Dis. 2023. PMID: 37308819 Free PMC article.

2

[Impact of vaccination on admissions for Haemophilus influenzae b meningitis from 2004 to 2008 in Bobo Dioulasso, Burkina Faso].

Kaboré NF, Poda GE, Barro M, Cessouma R, Héma A, Ouedraogo AS, Sawadogo AB, Nacro B. Kaboré NF, et al. Med Sante Trop. 2012 Oct-Dec;22(4):425-9. doi: 10.1684/mst.2012.0122. Med Sante Trop. 2012. PMID: 23360620 Free article. French.

3

Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso.

Bado G, Penot P, N'Diaye MD, Amiel C, Hema A, Kamboulé EB, Guiard-Schmid JB, Kaboré NF, Slama L, Bambara A, Laurent C, Sangaré L, Sawadogo AB. Bado G, et al. Among authors: kabore nf. Med Mal Infect. 2013 May;43(5):202-7. doi: 10.1016/j.medmal.2013.04.001. Epub 2013 May 20. Med Mal Infect. 2013. PMID: 23701923

4

[Metabolic syndrome and cardiovascular risk patients under antiretrovirals in a day hospital at Bobo-Dioulasso (Burkina Faso)].

Sawadogo A, Sanou S, Hema A, Kamboule BE, Kabore NF, Sore I, Konate A, Poda GE, Zoungrana J, Sawadogo AB. Sawadogo A, et al. Among authors: kabore nf. Bull Soc Pathol Exot. 2014 Aug;107(3):151-8. doi: 10.1007/s13149-014-0371-8. Epub 2014 Jun 23. Bull Soc Pathol Exot. 2014. PMID: 24953144 French.

5

[Characteristics of Low-Level Persistent viraemias in HIV-1 Patients Treated with Second-Line ARVs at the Sourô Sanou Teaching Hospital of Bobo-Dioulasso (Burkina Faso)].

Zoungrana J, Kyelem CG, Sondo KA, Naibi KA, Hema A, Kabore NF, Poda A, Bado A, Yaméogo I, Séré H, Ouedraogo AS, Tani S, Tarnagda Z. Zoungrana J, et al. Among authors: kabore nf. Bull Soc Pathol Exot. 2018;111(3):161-166. doi: 10.3166/bspe-2018-0039. Bull Soc Pathol Exot. 2018. PMID: 30793572 French.

6

Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.

Kaboré NF, Poda A, Zoungrana J, Da O, Ciaffi L, Semdé A, Yaméogo I, Sawadogo AB, Delaporte E, Meda N, Limou S, Cournil A. Kaboré NF, et al. BMC Nephrol. 2019 May 7;20(1):155. doi: 10.1186/s12882-019-1335-9. BMC Nephrol. 2019. PMID: 31064340 Free PMC article.

7

Serotype Profile of Nasopharyngeal Isolates of Streptococcus pneumoniae Obtained from Children in Burkina Faso before and after Mass Administration of Azithromycin.

Hema-Ouangraoua S, Zongo I, Kabore NF, Frédéric N, Yerbanga RS, Tinto H, Compaore YD, Kuepfer I, Chandramohan D, Greenwood B, Ouedraogo JB. Hema-Ouangraoua S, et al. Among authors: kabore nf. Am J Trop Med Hyg. 2020 Aug;103(2):679-683. doi: 10.4269/ajtmh.19-0944. Epub 2020 Jun 4. Am J Trop Med Hyg. 2020. PMID: 32524945 Free PMC article.

8

Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration.

Poda A, Kabore NF, Malateste K, De Rekeneire N, Semde A, Bikinga Y, Patassi A, Chenal H, Messou E, Dabis F, Ekouevi DK, Jaquet A, Cournil A. Poda A, et al. Among authors: kabore nf. HIV Med. 2021 Feb;22(2):113-121. doi: 10.1111/hiv.12982. Epub 2020 Nov 3. HIV Med. 2021. PMID: 33145918 Free PMC article.

9

Impact of mass administration of azithromycin as a preventive treatment on the prevalence and resistance of nasopharyngeal carriage of Staphylococcus aureus.

Hema-Ouangraoua S, Tranchot-Diallo J, Zongo I, Kabore NF, Nikièma F, Yerbanga RS, Tinto H, Chandramohan D, Ouedraogo GA, Greenwood B, Ouedraogo JB. Hema-Ouangraoua S, et al. Among authors: kabore nf. PLoS One. 2021 Oct 13;16(10):e0257190. doi: 10.1371/journal.pone.0257190. eCollection 2021. PLoS One. 2021. PMID: 34644317 Free PMC article. Clinical Trial.

10

APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa.

Kabore NF, Cournil A, Poda A, Ciaffi L, Binns-Roemer E, David V, Eymard-Duvernay S, Zoungrana J, Semde A, Sawadogo AB, Koulla-Shiro S, Kouanfack C, Ngom-Gueye NF, Meda N, Winkler C, Limou S. Kabore NF, et al. Kidney Int Rep. 2021 Oct 16;7(3):483-493. doi: 10.1016/j.ekir.2021.10.009. eCollection 2022 Mar. Kidney Int Rep. 2021. PMID: 35257061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters